Fetuin-A, inter-α-trypsin inhibitor, glutamic acid and ChoE (18:0) are key biomarkers in a panel distinguishing mild from critical coronavirus disease 2019 outcomes.

ABSTRACT:

SUBMITTER: Reverte L 

PROVIDER: S-EPMC8787095 | biostudies-literature | 2022 Jan

REPOSITORIES: biostudies-literature